Table 5.
Biomarker Levels in Different Sites
| Biomarkers N=168 | Femoral Vein | 95% CI | CS | 95% CI | LA | 95% CI | P Value |
|---|---|---|---|---|---|---|---|
| NT‐proBNP, pg/mL | 177.3 | 147.4 to 213.4 | 230.8 | 192.5 to 276.9 | 171.9 | 142.8 to 207 | <0.001 |
| MR‐proANP, pmol/L | 128.7 | 118.6 to 139.6 | 184.7 | 170.3 to 200.4 | 132 | 121.7 to 143.2 | <0.001 |
| Copeptin, pmol/L | 8.59 | 7.46 to 9.88 | 8.56 | 7.39 to 9.91 | 8.39 | 7.24 to 9.73 | 0.402 |
| MR‐proADM, nmol/L | 0.676 | 0.648 to 0.704 | 0.646 | 0.619 to 0.674 | 0.623 | 0.594 to 0.639 | <0.001 |
Data are presented as geometric means with 95% CI, but MR‐proADM is presented as mean with 95% CI. Analyses were performed with repeated‐measurements ANOVA and were adjusted for covariates: BMI >30, GFR <60 mL/min per 1.73 m2, EF <50%, age >65 years, heart rate >100/min, E/E′, and sex. The potential statistical significance of those analyses is presented with P values. BMI indicates body mass index; EF, ejection fraction; GFR, glomerular filtration rate; MR‐proADM, midregional portion of proadrenomedullin; MR‐proANP, midregional fragment of the N‐terminal precursor of atrial natriuretic peptide; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.